Patent details
EP1057480 Title: Transdermal estrogen agonist-antagonist therapy
Basic Information
- Publication number:
- EP1057480
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP003046117
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Transdermal estrogen agonist-antagonist therapy
- French Title of Invention:
- Thérapie transdermique à base d'un agoniste-antagoniste d' oestrogène
- German Title of Invention:
- Transdermale Östrogen Agonist-Antagonist Therapie
- SPC Number:
Dates
- Filing date:
- 30/05/2000
- Grant date:
- 23/06/2004
- EP Publication Date:
- 23/06/2004
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 06/12/2000
- EP B1 Publication Date:
- 23/06/2004
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 30/05/2009
- Expiration date:
- 30/05/2020
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 30/05/2000
- Name:
- Pfizer Products Inc.
- Address:
- Eastern Point Road, Groton, Connecticut 06340, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 01/07/2004
- Address:
- PO Box 48, 8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
- Name:
- Da Silva-Jardine Paul Andrew
- Address:
- United States (US)
Priority
- Priority Number:
- 137164 P
- Priority Date:
- 01/06/1999
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 9/70;
| Filing date | Document type | Number of pages |
|---|